Robert L. DuPont, MD, FASAMBruce A. Goldberger, PhD, DABFTMark S. Gold, MD, FASAM CHAPTER112 CHAPTER OUTLINE ■ EVOLUTION OF DRUG TESTING ■ THE SCIENCE OF DRUG TESTING ■ ON-SITE VERSUS LABORATORY ANALYSIS ■ CHOICE…
Paul H. Earley, MD, FASAM CHAPTER41 CHAPTER OUTLINE ■ PREVALENCE ■ CHARACTERISTICS OF ADDICTED PHYSICIANS ■ DRUGS ABUSED ■ RISK FACTORS ■ ADDICTION COMORBIDITY ■ THEORIES OF ADDICTION AMONG PHYSICIANS ■ IDENTIFICATION, INTERVENTION, AND ASSESSMENT ■ TREATMENT ■ CONTROVERSIES…
Marc Fishman, MD CHAPTER105 CHAPTER OUTLINE ■ DEVELOPMENTAL CONSIDERATIONS IN ADOLESCENT PLACEMENT ■ THE ASAM PATIENT PLACEMENT CRITERIA ■ CONCLUSIONS Although the fields of adolescent treatment in general and adolescent treatment outcomes research…
Richard Saitz, MD, MPH, FACP, FASAM CHAPTER72 CHAPTER OUTLINE ■ ROUTINE AND PREVENTIVE CARE ■ CARE DURING HOSPITALIZATION ■ MEDICAL CONSEQUENCES OF ALCOHOL, TOBACCO, AND OTHER DRUG USE ■ COMMON MEDICAL PROBLEMS IN PERSONS…
Ursula Whiteside, PhDJoyce N. Bittinger, PhDJason R. Kilmer, PhDTy W. Lostutter, PhDMary E. Larimer, PhD CHAPTER38 CHAPTER OUTLINE ■ PREVALENCE AND CONSEQUENCES ■ PREVENTION STRATEGIES AND INTERVENTIONS ■ CONCLUSIONS AND FUTURE DIRECTIONS PREVALENCE…
P. Joseph Frawley, MDMatthew O. Howard, MD CHAPTER62 CHAPTER OUTLINE ■ AVERSION THERAPY AS PART OF A MULTIMODALITY TREATMENT PROGRAM ■ PRINCIPLES OF CONDITIONING ■ USES OF AVERSION THERAPY ■ EFFECT OF AVERSION ON…
Laura M. Juliano, PhDSergi Ferré, MD, PhDRoland R. Griffiths, PhD CHAPTER11 CHAPTER OUTLINE ■ DRUGS IN THE CLASS ■ HISTORY ■ EPIDEMIOLOGY ■ SOURCES OF CAFFEINE ■ THERAPEUTIC USES ■ NEUROBIOLOGY ■ PHARMACOKINETICS ■ PHYSIOLOGIC EFFECTS ■ SUBJECTIVE EFFECTS…
